BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
5.93
-0.50 (-7.78%)
At close: Jul 7, 2025, 4:00 PM
5.71
-0.22 (-3.71%)
After-hours: Jul 7, 2025, 7:51 PM EDT
BioNexus Gene Lab Market Cap
BioNexus Gene Lab has a market cap or net worth of $10.65 million as of July 7, 2025. Its market cap has increased by 34.00% in one year.
Market Cap
10.65M
Enterprise Value
7.27M
1-Year Change
34.00%
Ranking
Category
Stock Price
$5.93
Market Cap Chart
Since September 16, 2020, BioNexus Gene Lab's market cap has decreased from $42.12M to $10.65M, a decrease of -74.71%. That is a compound annual growth rate of -24.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 11.55M | 129.87% |
| Dec 31, 2024 | 5.03M | -46.33% |
| Dec 29, 2023 | 9.36M | -94.33% |
| Dec 30, 2022 | 165.03M | -54.75% |
| Dec 31, 2021 | 364.69M | 54.35% |
| Dec 31, 2020 | 236.28M | 460.98% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Linde | 221.05B |
| BHP Group | 127.64B |
| Rio Tinto Group | 99.07B |
| The Sherwin-Williams Company | 86.60B |
| Southern Copper | 84.03B |
| Ecolab | 77.05B |
| Newmont | 66.23B |
| Freeport-McMoRan | 64.82B |